Verastem Announces Publication of Phase 2 Study Results in Indolent Non-Hodgkin Lymphoma in the Journal of Clinical Oncology February 14, 2019
Bicycle Therapeutics Awarded SBRI Contract to Address Antimicrobial Resistance in Humans February 12, 2019
Calithera Completes Patient Enrollment in Randomized Phase 2 Trial in Renal Cell Carcinoma February 4, 2019
PTC Therapeutics Launches New Program to Support Research Projects in Rare, Genetic Disorders January 31, 2019
